(S (NP (DT The) (NNP COVID-19) (NN pandemic)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT a) (JJ major) (NN challenge)) (PP (TO to) (NP (NN humanity)))) (, ,) (PP (IN with) (NP (NP (NP (QP (CD 12.7) (CD million)) (JJ confirmed) (NNS cases)) (PP (IN as) (PP (IN of) (NP (NNP July) (CD 13th) (, ,) (CD 2020))))) (PRN (NN -LSB-) (CD 1) (NN -RSB-)))))) (. .))
(S (PP (IN In) (NP (JJ previous) (NN work))) (, ,) (NP (PRP we)) (VP (VBD described) (SBAR (WHADVP (WRB how)) (S (NP (JJ Artificial) (NN Intelligence)) (VP (MD can) (VP (VB be) (VP (VP (VBN used) (S (VP (TO to) (VP (VB tackle) (NP (DT the) (JJ pandemic)) (PP (IN with) (NP (NP (NNS applications)) (PP (IN at) (NP (DT the) (JJ molecular) (, ,) (JJ clinical) (, ,) (CC and) (JJ societal) (NNS scales))))))))) (PRN (VBP -LSB-) (CD 2) (NN -RSB-)))))))) (. .))
(S (PP (IN In) (NP (DT the) (JJ present) (JJ follow-up) (NN article))) (, ,) (NP (PRP we)) (VP (VP (VBP review) (NP (DT these) (CD three) (NN research) (NNS directions))) (, ,) (CC and) (VP (IN assess) (NP (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN maturity) (CC and) (NN feasibility))) (PP (IN of) (NP (NP (DT the) (NNS approaches)) (VP (VBN used))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (PRP$ their) (NN potential)) (PP (IN for) (NP (NN operationalization))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBP summarize) (NP (NP (DT some) (NX (NX (ADJP (RB commonly) (JJ encountered)) (NX (NNS risks))) (CC and) (NX (JJ practical) (NNS pitfalls)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (NNS guidelines)) (CC and) (NP (JJS best) (NNS practices))) (PP (IN for) (S (VP (VBG formulating) (CC and) (VBG deploying) (NP (NNP AI) (NNS applications)) (PP (IN at) (NP (JJ different) (NNS scales))))))))) (. .))
